The use of blood tests, particularly of p-tau217, in the diagnosis of Alzheimer’s disease has taken off in the last few years, with the number of tests being prescribed now doubling every four to six ...

In memory clinics and in research cohorts, immunoassays for plasma markers can now distinguish people who have Alzheimer’s disease pathology with remarkable accuracy (see Part 7 of this series). How ...

In psychopathology, the p-factor suggests the presence of a common factor driving various mental health disorders. A recent Translational Psychiatry study aimed to discover p-factor-related plasma ...